Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa
Romain Guéry(Hôpital Necker-Enfants Malades), Ambroise Marçais(Hôpital Necker-Enfants Malades), Felipe Suárez(Hôpital Necker-Enfants Malades), Philippe Hélias(Centre Hospitalier Universitaire Pointe-à-Pitre), P. Renaudier(Centre Hospitalier Universitaire de Martinique), Jean‐Herlé Raphalen(Assistance Publique – Hôpitaux de Paris), Olivier Lortholary(Hôpital Necker-Enfants Malades), Fanny Lanternier(Institut Pasteur), Olivier Hermine(Délégation Paris 5), Marc Lecuit(Délégation Paris 5), Hervé Lécuyer(Délégation Paris 5), Marie‐Elisabeth Bougnoux(Hôpital Necker-Enfants Malades), David Sibon(Hôpital Necker-Enfants Malades), Claire Aguilar(Hôpital Necker-Enfants Malades), Florin Santa, Laurent Frenzel(Hôpital Necker-Enfants Malades), Véronique Avettand-Fènoël(Hôpital Necker-Enfants Malades)
Cited by 19
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k